This PDF is the current document as it appeared on Public Inspection on 02/23/2017 at 08:45 am.
ICD-10 Coordination and Maintenance (C&M) Committee meeting.
Time and Date:
9:00 a.m.-5:00 p.m., EST, March 7-8, 2017Start Printed Page 11578
Centers for Medicare and Medicaid Services (CMS) Auditorium, 7500 Security Boulevard, Baltimore, Maryland 21244
Open to the public, limited only by the space available. The meeting room accommodates approximately 240 people. We will be broadcasting the meeting live via Webcast at http://www.cms.gov/live/.
Due to increased security requirements CMS has instituted stringent procedures for entrance into the building by non-government employees. Attendees will need to present valid government-issued picture identification, and sign-in at the security desk upon entering the building.
Attendees who wish to attend the March 7-8, 2017 ICD-10-CM C&M meeting must submit their name and organization by February 24, 2016 for inclusion on the visitor list. This visitor list will be maintained at the front desk of the CMS building and used by the guards to admit visitors to the meeting.
Participants who attended previous Coordination and Maintenance meetings will no longer be automatically added to the visitor list. You must request inclusion of your name prior to each meeting you wish attend.
Please register to attend the meeting on-line at: http://www.cms.hhs.gov/apps/events/. Please contact Mady Hue (410-786-4510 or Marilu.firstname.lastname@example.org), for questions about the registration process.
The ICD-10 Coordination and Maintenance (C&M) Committee is a public forum for the presentation of proposed modifications to the International Classification of Diseases, Tenth Revision, Clinical Modification and ICD-10 Procedure Coding System.
Matters for Discussion:
Agenda items include:
March 7-8, 2017
Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement
Renal Replacement Therapy
Magnetically Controlled Growth Rods
Oxidized Zirconium Polyethylene Implant for Hip and Knee Replacement
Endovascular Intracranial Thrombectomy
Radiotherapeutic Brain Implant
Combined Thoracic Arch Replacement and Thoracic Aorta Restriction
Occlusion of Left Atrial Appendage
Spinal Fusion with Radiolucent Interbody Fusion Device
Administration of ZINPLAVA (Bezlotoxumab)
Administration of VYXEOS
Administration of KTE-C19 (axicabtageneciloleucel) Congenital Anomaly Procedures
Resection of the Left Ventricular
Outflow Tract Obstruction and/or Subaortic Membrane(Stenosis)
Fontan Completion Procedure, Stage II
Ligation of Pulmonary Trunk
Fluoroscopy of Pulmonary Trunk
Modified Blalock-Taussig Shunt
Release of Myocardial Bridge
Addenda and Key Updates
ICD-10-CM Diagnosis Topics:
Atrial Fibrillation (AF)
Diverticular Disease of Intestine
Encounter for examination of eyes and vision with abnormal findings
Fetal Inflammatory Response Syndrome
Hepatic Encephalopathy (re-presentation)
Meibomian Gland Dysfunction
Glasgow Coma Scale, Pediatric
Personal History of Mesothelioma and Secondary Mesothelioma
Post Endometrial Ablation Syndrome
Sickle Cell w/o Acute Chest Syndrome or Splenic Sequestration
Surgical Site Infection
Types of Myocardial Infarctions (MI)
Agenda items are subject to change as priorities dictate.
Note: CMS and NCHS no longer provide paper copies of handouts for the meeting. Electronic copies of all meeting materials will be posted on the CMS and NCHS Web sites prior to the meeting at http://www.cms.hhs.gov/ICD9ProviderDiagnosticCodes/03_meetings.asp#TopOfPage and http://www.cdc.gov/nchs/icd/icd9cm_maintenance.htm.
Contact Persons for Additional Information:
Donna Pickett, Medical Systems Administrator, Classifications and Public Health Data Standards Staff, NCHS, 3311 Toledo Road Hyattsville, Maryland 20782, email email@example.com, telephone 301-458-4434 (diagnosis); Mady Hue, Health Insurance Specialist, Division of Acute Care, CMS, 7500 Security Boulevard, Baltimore, Maryland, 21244, email firstname.lastname@example.org, telephone 410-786-4510 (procedures).
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry.Start Signature
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 2017-03627 Filed 2-23-17; 8:45 am]
BILLING CODE 4163-18-P